Edgewise Therapeutics Net Non-Operating Interest Income Expense (Quarterly) Analysis

Edgewise Therapeutics, Inc. (EWTX)

24.70 +0.16 (+0.63%) USD | NASDAQ | Dec 31, 14:59

View Net Non-Operating Interest Income Expense (Quarterly) for EWTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Non-Operating Interest Income Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

Start Trial

Dynavax Technologies Corp.	Upgrade
Omeros Corp.	Upgrade
Gilead Sciences, Inc.	Upgrade
Agios Pharmaceuticals, Inc.	Upgrade
NovaBay Pharmaceuticals, Inc.	Upgrade